OPTHEA LIMITED - Announcements

0.00%

60.0¢

Market Cap $820.7M

Healthcare Biotechnology

Opthea Limited is an Australia-based clinical-stage biopharmaceutical company. The... Opthea Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is engaged in developing novel therapies to address the unmet need in the treatment of prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). Its lead product candidate, sozinibercept (OPT-302), is being evaluated in two pivotal Phase 3 clinical trials for use in combination with standard-of-care anti-VEGF-A monotherapies for the treatment of wet AMD and DME. The Company has also manufactured OPT-302 for use in Phase III clinical trials, conducts activities to support the commercialization of the product and expanded its management team in the United States to facilitate broader oversight and execution of its Phase III program. Its development activities are based on an intellectual property portfolio covering key targets (Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3).More

MEMPHASYS LIMITED

Many are concerned about global falling birthrates. This diverse stock has solutions. Here, then, one can’t afford to miss perusing what ASX-listed fertility tech healthcare smallcap Memphasys Ltd (ASX:MEM) can offer the world.

Announcements

Filter Results

All Price Sensitive Only

OPT	Opthea Presents at the 2023 Ophthalmology Innovation Summit		25/07/23	127.88KB	Share
OPT	Opthea to Feature at the ASRS 2023 Annual Meeting		14/07/23	117.23KB	Share
OPT	Opthea Announces Appointment of Snr Medical Advisor		11/07/23	99.11KB	Share
OPT	Change in substantial holding		23/06/23	91.67KB	Share
OPT	Final Director's Interest Notice MS		09/06/23	270.18KB	Share
OPT	Initial Director's Interest Notice AT		09/06/23	201.68KB	Share
OPT	Opthea Appoints Anshul Thakral as Non-Executive Director		09/06/23	131.26KB	Share
OPT	Ceasing to be a substantial holder		02/06/23	145.85KB	Share
OPT	Opthea Presents at the Jefferies 2023 Healthcare Conference		26/05/23	127.79KB	Share
OPT	Opthea participates in EF Hutton hosted webinar on OPT-302		18/05/23	127.12KB	Share
OPT	Change in substantial holding		17/05/23	218.18KB	Share
OPT	Opthea Presents at JMP Securities Life Sciences Conference		09/05/23	146.44KB	Share
OPT	Opthea to Participate at HC Wainwright BioConnect Conference		28/04/23	126.58KB	Share
OPT	Becoming a substantial holder		20/03/23	223.22KB	Share
OPT	Opthea Receives A$8.7million R&D Tax Incentive	PRICE SENSITIVE	07/03/23	159.63KB	Share
OPT	Opthea to participate at Oppenheimer's Healthcare Conference		07/03/23	134.78KB	Share
OPT	Half Year Accounts	PRICE SENSITIVE	23/02/23	1.31MB	Share
OPT	Response to ASX Query	PRICE SENSITIVE	16/02/23	314.34KB	Share
OPT	Opthea Ph2b Trial Results with OPT-302 published in Journal	PRICE SENSITIVE	14/02/23	103.86KB	Share
OPT	Appendix 2A		10/02/23	596.06KB	Share
OPT	Opthea to present at SVB Leerink Global Biopharma Conference		07/02/23	140.44KB	Share
OPT	Opthea to Present at Sequire Biotechnology Conference		31/01/23	94.75KB	Share
OPT	Opthea Corporate Presentation - San Francisco Jan 2023	PRICE SENSITIVE	11/01/23	1.13MB	Share
OPT	Opthea Announces MST Conference call with Jason Slakter MD		13/12/22	98.8KB	Share
OPT	Opthea to present at the FLORetina 2022 Congress		07/12/22	126.41KB	Share
OPT	Cleansing Notice		30/11/22	211.76KB	Share
OPT	Appendix 2A		30/11/22	273.2KB	Share
OPT	Appendix 2A		29/11/22	273.68KB	Share
OPT	Cleansing Notice		29/11/22	211.56KB	Share
OPT	Appendix 3Y MS		29/11/22	236.35KB	Share
OPT	Appendix 3Y MB		29/11/22	236.92KB	Share
OPT	Notification regarding unquoted securities - OPT		16/11/22	24.95KB	Share
OPT	Notification regarding unquoted securities - OPT		16/11/22	26.33KB	Share
OPT	Notification regarding unquoted securities - OPT		16/11/22	26.51KB	Share
OPT	Results of Meeting		16/11/22	330.62KB	Share
OPT	Chairman's Address to Shareholders	PRICE SENSITIVE	16/11/22	170.52KB	Share
OPT	Opthea to Present at Jefferies London Healthcare Conference		11/11/22	125.4KB	Share
OPT	Appendix 2A		28/10/22	273.2KB	Share
OPT	Cleansing Notice		28/10/22	211.45KB	Share
OPT	Opthea Expands Leadership Team with CFO Appointment		25/10/22	205.62KB	Share
OPT	Notice of General Meeting/Proxy Form		17/10/22	820.21KB	Share
OPT	Change in substantial holding		05/10/22	90.99KB	Share
OPT	Change in substantial holding		05/10/22	1.52MB	Share
OPT	Cleansing Notice		03/10/22	222.41KB	Share
OPT	Application for quotation of securities - OPT		30/09/22	23.17KB	Share
OPT	Results of Meeting		26/09/22	181.87KB	Share
OPT	Application for quotation of securities - OPT		26/09/22	24.67KB	Share
OPT	Completion of Share Purchase Plan	PRICE SENSITIVE	26/09/22	151.39KB	Share
OPT	Opthea Appendix 4G Corporate Governance Statement 2022		30/08/22	723.04KB	Share
OPT	Opthea reports Fiscal Year 2022 Results and Highlights	PRICE SENSITIVE	30/08/22	151.49KB	Share
OPT	Opthea Appendix 4E and Annual Report 2022	PRICE SENSITIVE	30/08/22	3.07MB	Share
OPT	Change in substantial holding		29/08/22	90KB	Share
OPT	Change in substantial holding		29/08/22	1.49MB	Share
OPT	Change in substantial holding		25/08/22	275.27KB	Share
OPT	Opthea Share Purchase Plan	PRICE SENSITIVE	25/08/22	898.25KB	Share
OPT	Cleansing Notice		25/08/22	215.88KB	Share
OPT	Update - Application for quotation of securities - OPT		24/08/22	23.01KB	Share
OPT	Application for quotation of securities - OPT		24/08/22	23.42KB	Share
OPT	Notice of Extraordinary General Meeting/Proxy Form		23/08/22	364.74KB	Share
OPT	Opthea to Present at H.C. Wainwright 2nd Annual Conference		17/08/22	94.48KB	Share
OPT	Form 6-K with SEC	PRICE SENSITIVE	15/08/22	141.27KB	Share
OPT	Opthea Successfully Closes Well Supported US$90m Financing	PRICE SENSITIVE	15/08/22	127.5KB	Share
OPT	Proposed issue of securities - OPT		15/08/22	27.86KB	Share
OPT	Proposed issue of securities - OPT		15/08/22	25.57KB	Share
OPT	Opthea secures up to US$170m in non-dilutive financing	PRICE SENSITIVE	15/08/22	137.42KB	Share
OPT	Trading Halt	PRICE SENSITIVE	11/08/22	273.91KB	Share
OPT	Notification regarding unquoted securities - OPT		29/07/22	25.67KB	Share
OPT	Notification regarding unquoted securities - OPT		29/07/22	25.32KB	Share
OPT	Notification regarding unquoted securities - OPT		29/07/22	25.58KB	Share
OPT	Ceasing to be a substantial holder		22/06/22	421.13KB	Share
OPT	Becoming a substantial holder		08/06/22	811.13KB	Share
OPT	Change in substantial holding		07/06/22	625.55KB	Share
OPT	Cleansing Notice		27/05/22	211.33KB	Share
OPT	Appendix 2A		27/05/22	272.61KB	Share
OPT	Ceasing to be a substantial holder		26/05/22	81.05KB	Share
OPT	Change in substantial holding		24/05/22	111.76KB	Share
OPT	Change in substantial holding		16/05/22	89.52KB	Share
OPT	Opthea To Present at Upcoming Investor Conferences		12/05/22	141.01KB	Share
OPT	Opthea Presentation at The Retina World Congress 2022		11/05/22	130.47KB	Share
OPT	Opthea Data for OPT-302 for PCV presented at ARVO 2022	PRICE SENSITIVE	06/05/22	164.12KB	Share
OPT	Change in substantial holding		03/05/22	316.2KB	Share
OPT	Opthea Presenting Clinical Data at ARVO 2022 Annual Meeting	PRICE SENSITIVE	02/05/22	104.6KB	Share
OPT	Change in substantial holding		28/04/22	70.84KB	Share
OPT	Change in substantial holding		26/04/22	332.89KB	Share
OPT	Initial Director's Interest Notice - QO		26/04/22	201.41KB	Share
OPT	Initial Director's Interest Notice - SO		26/04/22	201.2KB	Share
OPT	Opthea strengthens its Board of Directors		26/04/22	123.02KB	Share
OPT	Results of Meeting		21/04/22	178.1KB	Share
OPT	Ceasing to be a substantial holder		20/04/22	166.74KB	Share
OPT	Change in substantial holding		12/04/22	321.7KB	Share
OPT	Change in substantial holding		11/04/22	317.53KB	Share
OPT	Change in substantial holding		31/03/22	63.38KB	Share
OPT	Change in substantial holding		30/03/22	304.43KB	Share
OPT	Change in substantial holding		29/03/22	522.13KB	Share
OPT	Change in substantial holding		25/03/22	141.46KB	Share
OPT	Change in substantial holding		24/03/22	503.06KB	Share
OPT	Change in substantial holding		15/03/22	62.69KB	Share
OPT	Notice of General Meeting and Proxy Form		15/03/22	1.26MB	Share
OPT	Change in substantial holding		14/03/22	307.66KB	Share
OPT	Change in substantial holding		14/03/22	314.56KB	Share

OPT Opthea Presents at the 2023 Ophthalmology Innovation Summit
25/07/23		127.88KB	Share
OPT Opthea to Feature at the ASRS 2023 Annual Meeting
14/07/23		117.23KB	Share
OPT Opthea Announces Appointment of Snr Medical Advisor
11/07/23		99.11KB	Share
OPT Change in substantial holding
23/06/23		91.67KB	Share
OPT Final Director's Interest Notice MS
09/06/23		270.18KB	Share
OPT Initial Director's Interest Notice AT
09/06/23		201.68KB	Share
OPT Opthea Appoints Anshul Thakral as Non-Executive Director
09/06/23		131.26KB	Share
OPT Ceasing to be a substantial holder
02/06/23		145.85KB	Share
OPT Opthea Presents at the Jefferies 2023 Healthcare Conference
26/05/23		127.79KB	Share
OPT Opthea participates in EF Hutton hosted webinar on OPT-302
18/05/23		127.12KB	Share
OPT Change in substantial holding
17/05/23		218.18KB	Share
OPT Opthea Presents at JMP Securities Life Sciences Conference
09/05/23		146.44KB	Share
OPT Opthea to Participate at HC Wainwright BioConnect Conference
28/04/23		126.58KB	Share
OPT Becoming a substantial holder
20/03/23		223.22KB	Share
OPT Opthea Receives A$8.7million R&D Tax Incentive
07/03/23	PRICE SENSITIVE	159.63KB	Share
OPT Opthea to participate at Oppenheimer's Healthcare Conference
07/03/23		134.78KB	Share
OPT Half Year Accounts
23/02/23	PRICE SENSITIVE	1.31MB	Share
OPT Response to ASX Query
16/02/23	PRICE SENSITIVE	314.34KB	Share
OPT Opthea Ph2b Trial Results with OPT-302 published in Journal
14/02/23	PRICE SENSITIVE	103.86KB	Share
OPT Appendix 2A
10/02/23		596.06KB	Share
OPT Opthea to present at SVB Leerink Global Biopharma Conference
07/02/23		140.44KB	Share
OPT Opthea to Present at Sequire Biotechnology Conference
31/01/23		94.75KB	Share
OPT Opthea Corporate Presentation - San Francisco Jan 2023
11/01/23	PRICE SENSITIVE	1.13MB	Share
OPT Opthea Announces MST Conference call with Jason Slakter MD
13/12/22		98.8KB	Share
OPT Opthea to present at the FLORetina 2022 Congress
07/12/22		126.41KB	Share
OPT Cleansing Notice
30/11/22		211.76KB	Share
OPT Appendix 2A
30/11/22		273.2KB	Share
OPT Appendix 2A
29/11/22		273.68KB	Share
OPT Cleansing Notice
29/11/22		211.56KB	Share
OPT Appendix 3Y MS
29/11/22		236.35KB	Share
OPT Appendix 3Y MB
29/11/22		236.92KB	Share
OPT Notification regarding unquoted securities - OPT
16/11/22		24.95KB	Share
OPT Notification regarding unquoted securities - OPT
16/11/22		26.33KB	Share
OPT Notification regarding unquoted securities - OPT
16/11/22		26.51KB	Share
OPT Results of Meeting
16/11/22		330.62KB	Share
OPT Chairman's Address to Shareholders
16/11/22	PRICE SENSITIVE	170.52KB	Share
OPT Opthea to Present at Jefferies London Healthcare Conference
11/11/22		125.4KB	Share
OPT Appendix 2A
28/10/22		273.2KB	Share
OPT Cleansing Notice
28/10/22		211.45KB	Share
OPT Opthea Expands Leadership Team with CFO Appointment
25/10/22		205.62KB	Share
OPT Notice of General Meeting/Proxy Form
17/10/22		820.21KB	Share
OPT Change in substantial holding
05/10/22		90.99KB	Share
OPT Change in substantial holding
05/10/22		1.52MB	Share
OPT Cleansing Notice
03/10/22		222.41KB	Share
OPT Application for quotation of securities - OPT
30/09/22		23.17KB	Share
OPT Results of Meeting
26/09/22		181.87KB	Share
OPT Application for quotation of securities - OPT
26/09/22		24.67KB	Share
OPT Completion of Share Purchase Plan
26/09/22	PRICE SENSITIVE	151.39KB	Share
OPT Opthea Appendix 4G Corporate Governance Statement 2022
30/08/22		723.04KB	Share
OPT Opthea reports Fiscal Year 2022 Results and Highlights
30/08/22	PRICE SENSITIVE	151.49KB	Share
OPT Opthea Appendix 4E and Annual Report 2022
30/08/22	PRICE SENSITIVE	3.07MB	Share
OPT Change in substantial holding
29/08/22		90KB	Share
OPT Change in substantial holding
29/08/22		1.49MB	Share
OPT Change in substantial holding
25/08/22		275.27KB	Share
OPT Opthea Share Purchase Plan
25/08/22	PRICE SENSITIVE	898.25KB	Share
OPT Cleansing Notice
25/08/22		215.88KB	Share
OPT Update - Application for quotation of securities - OPT
24/08/22		23.01KB	Share
OPT Application for quotation of securities - OPT
24/08/22		23.42KB	Share
OPT Notice of Extraordinary General Meeting/Proxy Form
23/08/22		364.74KB	Share
OPT Opthea to Present at H.C. Wainwright 2nd Annual Conference
17/08/22		94.48KB	Share
OPT Form 6-K with SEC
15/08/22	PRICE SENSITIVE	141.27KB	Share
OPT Opthea Successfully Closes Well Supported US$90m Financing
15/08/22	PRICE SENSITIVE	127.5KB	Share
OPT Proposed issue of securities - OPT
15/08/22		27.86KB	Share
OPT Proposed issue of securities - OPT
15/08/22		25.57KB	Share
OPT Opthea secures up to US$170m in non-dilutive financing
15/08/22	PRICE SENSITIVE	137.42KB	Share
OPT Trading Halt
11/08/22	PRICE SENSITIVE	273.91KB	Share
OPT Notification regarding unquoted securities - OPT
29/07/22		25.67KB	Share
OPT Notification regarding unquoted securities - OPT
29/07/22		25.32KB	Share
OPT Notification regarding unquoted securities - OPT
29/07/22		25.58KB	Share
OPT Ceasing to be a substantial holder
22/06/22		421.13KB	Share
OPT Becoming a substantial holder
08/06/22		811.13KB	Share
OPT Change in substantial holding
07/06/22		625.55KB	Share
OPT Cleansing Notice
27/05/22		211.33KB	Share
OPT Appendix 2A
27/05/22		272.61KB	Share
OPT Ceasing to be a substantial holder
26/05/22		81.05KB	Share
OPT Change in substantial holding
24/05/22		111.76KB	Share
OPT Change in substantial holding
16/05/22		89.52KB	Share
OPT Opthea To Present at Upcoming Investor Conferences
12/05/22		141.01KB	Share
OPT Opthea Presentation at The Retina World Congress 2022
11/05/22		130.47KB	Share
OPT Opthea Data for OPT-302 for PCV presented at ARVO 2022
06/05/22	PRICE SENSITIVE	164.12KB	Share
OPT Change in substantial holding
03/05/22		316.2KB	Share
OPT Opthea Presenting Clinical Data at ARVO 2022 Annual Meeting
02/05/22	PRICE SENSITIVE	104.6KB	Share
OPT Change in substantial holding
28/04/22		70.84KB	Share
OPT Change in substantial holding
26/04/22		332.89KB	Share
OPT Initial Director's Interest Notice - QO
26/04/22		201.41KB	Share
OPT Initial Director's Interest Notice - SO
26/04/22		201.2KB	Share
OPT Opthea strengthens its Board of Directors
26/04/22		123.02KB	Share
OPT Results of Meeting
21/04/22		178.1KB	Share
OPT Ceasing to be a substantial holder
20/04/22		166.74KB	Share
OPT Change in substantial holding
12/04/22		321.7KB	Share
OPT Change in substantial holding
11/04/22		317.53KB	Share
OPT Change in substantial holding
31/03/22		63.38KB	Share
OPT Change in substantial holding
30/03/22		304.43KB	Share
OPT Change in substantial holding
29/03/22		522.13KB	Share
OPT Change in substantial holding
25/03/22		141.46KB	Share
OPT Change in substantial holding
24/03/22		503.06KB	Share
OPT Change in substantial holding
15/03/22		62.69KB	Share
OPT Notice of General Meeting and Proxy Form
15/03/22		1.26MB	Share
OPT Change in substantial holding
14/03/22		307.66KB	Share
OPT Change in substantial holding
14/03/22		314.56KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 60.0¢		Change 0.000(0.00%)		Mkt cap ! $820.7M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

OPT (ASX) Chart

Day chart unavailable

OPTHEA LIMITED - Announcements

Announcements

Top Stories